Cargando…
Generation of αGal-enhanced bifunctional tumor vaccine
Hepatocellular carcinoma (HCC) is a common malignant tumor with poor prognosis and high mortality. In this study, we demonstrated a novel vaccine targeting HCC and tumor neovascular endothelial cells by fusing recombinant MHCC97H cells expressing porcine α-1,3-galactose epitopes (αGal) and endorphin...
Autores principales: | He, Jian, Huo, Yu, Zhang, Zhikun, Luo, Yiqun, Liu, Xiuli, Chen, Qiaoying, Wu, Pan, Shi, Wei, Wu, Tao, Tang, Chao, Wang, Huixue, Li, Lan, Liu, Xiyu, Huang, Yong, Zhao, Yongxiang, Gan, Lu, Wang, Bing, Zhong, Liping |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9293690/ https://www.ncbi.nlm.nih.gov/pubmed/35865091 http://dx.doi.org/10.1016/j.apsb.2022.03.002 |
Ejemplares similares
-
Aptamer‐based biosensors and application in tumor theranostics
por: Mo, Tong, et al.
Publicado: (2021) -
Generation of in situ CRISPR-mediated primary and metastatic cancer from monkey liver
por: Zhong, Liping, et al.
Publicado: (2021) -
Human endoglin-CD3 bispecific T cell engager antibody induces anti-tumor effect in vivo
por: Zhong, Liping, et al.
Publicado: (2021) -
Biosynthesis of α-Gal Epitopes (Galα1-3Galβ1-4GlcNAc-R) and Their Unique Potential in Future α-Gal Therapies
por: Galili, Uri
Publicado: (2021) -
A Dual Targeting Magnetic Nanoparticle for Human Cancer Detection
por: Wu, Siwen, et al.
Publicado: (2019)